Klas Therapeutics Limited

DataGardener
live
Micro

Klas Therapeutics Limited

ni676570Private Limited With Share Capital

C/O Cleaver Fulton Rankin, 50 Bedford Street, Belfast, BT27FW
Incorporated

16/02/2021

Company Age

5 years

Directors

4

Employees

4

SIC Code

72190

Risk

moderate risk

Company Overview

Registration, classification & business activity

Klas Therapeutics Limited (ni676570) is a private limited with share capital incorporated on 16/02/2021 (5 years old) and registered in belfast, BT27FW. The company operates under SIC code 72190 and is classified as Micro.

Private Limited With Share Capital
SIC: 72190
Micro
Incorporated 16/02/2021
BT27FW
4 employees

Financial Overview

Total Assets

£199.6K

Liabilities

£279.7K

Net Assets

£-80.1K

Cash

£102.7K

Key Metrics

4

Employees

4

Directors

6

Shareholders

Board of Directors

4

Filed Documents

25
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:24-02-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-06-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-02-2025
Change Person Director Company With Change Date
Category:Officers
Date:24-02-2025
Resolution
Category:Resolution
Date:18-09-2024
Capital Allotment Shares
Category:Capital
Date:17-09-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:12-09-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:10-05-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-02-2024
Capital Allotment Shares
Category:Capital
Date:20-02-2024
Capital Alter Shares Subdivision
Category:Capital
Date:20-02-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:19-02-2024
Memorandum Articles
Category:Incorporation
Date:19-02-2024
Memorandum Articles
Category:Incorporation
Date:19-02-2024
Resolution
Category:Resolution
Date:16-02-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-11-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-02-2023
Resolution
Category:Resolution
Date:20-02-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:16-12-2022
Capital Allotment Shares
Category:Capital
Date:17-11-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:17-11-2022
Gazette Filings Brought Up To Date
Category:Gazette
Date:11-05-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:10-05-2022
Gazette Notice Compulsory
Category:Gazette
Date:03-05-2022
Incorporation Company
Category:Incorporation
Date:16-02-2021

Innovate Grants

4

This company received a grant of £107602.0 for Product Optimisation Of A Novel New Melanoma Therapy Using Advanced Microscopy And Biomarkers To Enhance The Commercialisation Of This Technology.. The project started on 01/11/2023 and ended on 31/05/2025.

This company received a grant of £291086.0 for Klas Therapeutics Limited. The project started on 01/02/2024 and ended on 31/03/2025.

+2 more grants available

Risk Assessment

moderate risk

International Score

Future Factor

emerging

Performance Rating

Accounts

Typetotal exemption full
Due Date30/11/2026
Filing Date17/06/2025
Latest Accounts28/02/2025

Trading Addresses

48-50 Bedford Street, Belfast, BT27FWRegistered

Contact

klastherapeutics.com
C/O Cleaver Fulton Rankin, 50 Bedford Street, Belfast, BT27FW